Download Files:
Thalidomide-NH-(CH2)2-NH2 (TFA)
SKU
HY-W584514-Get quote
Category Reference compound
Tags Cancer, Ligands for E3 Ligase, PROTAC, Protein Tyrosine Kinase/RTK, SHP2
Size – Get quote
Products Details
Product Description
– Thalidomide-NH-(CH2)2-NH2 TFA is an alkyl-modified Thalidomide (HY-14658) that acts as a Cereblon ligand to recruit CRBN proteins. Thalidomide-NH-(CH2)2-NH2 TFA is a key intermediate in the synthesis of CRBN-based PROTAC molecules designed to synthesize small PROTAC molecules targeting SHP2 protein.
Web ID
– HY-W584514
Shipping
– Room temperature
Molecular Formula
– C17H17F3N4O6
CAS Number
– 1957235-67-4
Molecular Weight
– 430.34
SMILES
– O=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C=CC=C3NCCN)=O.O=C(O)C(F)(F)F
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Ligands for E3 Ligase, SHP2
Pathway
– PROTAC, Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.